Biggest News Aggregation in the World
📰 Looking Statement News

Page 51 - Looking Statement News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Looking Statement. Real-time updates on events, politics, business and more.

Merck & Co., Inc.: Merck Receives Positive CHMP Opinion for VAXNEUVANCE (Pneumococcal 15-valent Conjugate Vaccine) in Infants and Children

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended the
United States Julie Cunningham Alexis Constantine Kimberly Petrillo Peter Dannenbaum Eliav Barr

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Merck & Co (NYSE:MRK) – Five-Year Data for Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy Showed Sustained Survival Benefit Versus Chemotherapy Alone in Two Studies for Metastatic Non-Small Cell Lung Cancer (NSCLC) - Press Release

Five-year overall survival rate of 19.4% and 18.4% for KEYTRUDA plus chemotherapy in KEYNOTE-189 and KEYNOTE-407, respectively In first-line metastati
United States Marinac Garassino Eliav Barr Eli Lilly Merck Research Laboratories Statement Of Merck Co Inc

Merck & Co (NYSE:MRK) – Merck and Eisai Present Results From Phase 3 LEAP-002 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Versus LENVIMA Monotherapy in Patients With Unresectable Hepatocellular Carcinoma - Press Release

Findings to be featured in a late-breaking proffered paper session at European Society for Medical Oncology (ESMO) Congress 2022 Merck MRK, known as M
United States New Zealand France General Gregory Lubiniecki Corina Dutcus Eisai Europe Ltd

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science